Clinical trial
Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in…
NCT00003573 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003573 |
|---|---|
| Title | Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma |
| Official title | A Phase I/II Feasibility Study of Oral Etoposide Given Concurrently With Radiotherapy Followed With Dose Intensive Adjuvant Chemotherapy for Children With Newly Diagnosed High Stage Medulloblastoma |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain Tumors, Central Nervous System Tumors |
| Intervention type | Biological, Drug, Radiation |
| Interventions | filgrastim, cisplatin, cyclophosphamide, etoposide, vincristine sulfate, radiation therapy |
| Enrollment | 53 |
| Start date | Nov 1, 1998 |
| Primary completion | Oct 1, 2007 |
| Completion | Mar 1, 2008 |
| First posted | Feb 20, 2004 |
| Last update posted | Jul 25, 2014 |
| Countries | Canada, Netherlands, Puerto Rico, Switzerland, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: